Table I.
Baseline characteristics of study group
| Parameter | CoA (n = 58) 22 F/36 M | CG (n = 30) 12 F/18 M | P-value |
|---|---|---|---|
| Age [years] | 27.46 ±10.57 | 27.50 ±8.60 | 0.930 |
| Height [cm] | 172.05 ±10.81 | 174.07 ±8.91 | 0.383 |
| Weight [kg] | 73.21 ±15.06 | 73.30 ±14.14 | 0.978 |
| BMI [kg/m2] | 23.63 ±12.81 | 24.49 ±9.90 | 0.972 |
| BSA [m2] | 1.84 ±0.24 | 1.87 ±0.21 | 0.562 |
| Age at operation [years] | 8.68 ±8.64 | N/D | N/D |
| Follow-up [years] | 20.39 ±9.8 | N/D | N/D |
| Moderate MR (%) | 6.89 | 0 | N/D |
| Severe AS or AR (%) | 0 | 0 | N/D |
| Moderate AS (%) | 12.06 | 0 | N/D |
| Moderate AR (%) | 24.14 | 0 | N/D |
| Bicuspid aortic valve (%) | 62.06 | 0 | N/D |
| Aortic valve replacement (%) | 1.72 | 0 | N/D |
| Aortic aneurysm (%) | 0 | 0 | N/D |
| Aortic dilatation (%) | 13.79 | 0 | N/D |
| Bentall de Bono surgery (%) | 6.89 | 0 | N/D |
| Hypoplastic aortic arch (%) | 17.24 | 0 | N/D |
| Recoarctation (%) | 25.86 | 0 | N/D |
| Arterial hypertension (%) | 48.31 | 0 | N/D |
| Coronary artery intervention (%) | 6.89 | 0 | N/D |
| Cerebral vascular insult (%) | 0 | 0 | N/D |
| β-blocker therapy (%) | 53.4 | 0 | N/D |
| ACE inhibitor therapy (%) | 36.2 | 0 | N/D |
| AT1 blockers (%) | 6.9 | 0 | N/D |
| Ca blockers (%) | 17.2 | 0 | N/D |
| Diuretics therapy (%) | 22.4 | 0 | N/D |
| Statin therapy (%) | 34.2 | 0 | N/D |
| ASA (%) | 6.9 | 0 | N/D |
AR – aortic valve, regurgitation, AS – aortic valve stenosis, ASA – acetylsalicylic acid, BMI – body mass index, BSA – body surface area, MR – mitral valve regurgitation. Data are presented as means with standard deviation (mean ± SD) or as percentage (%) of total number; p-value ≤ 0.05 is considered as statistically significant.